Nitrilotriacetic acid

Genetic toxicity: in vitro

Administrative data

Endpoint:

in vitro gene mutation study in bacteria

Remarks:

Type of genotoxicity: gene mutation

Type of information:

migrated information: read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

weight of evidence

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: comparable to guidelines: the comprehensive validation programme provided unequivocally identical results among the institutes

Data source

Reference

Reference Type:

publication

Title:

Unnamed

Year:

1985

Materials and methods

Principles of method if other than guideline:

largely acc. to OECD Guideline 471

GLP compliance:

yes

Remarks:

testing lab.

Type of assay:

bacterial reverse mutation assay

Test material

Test material information

Constituent 1

Reference substance name:

18662-53-8

EC Number:

606-091-9

Cas Number:

18662-53-8

IUPAC Name:

18662-53-8

Details on test material:

Na3.NTA.H20, commercial

Method

Species / strain

Species / strain / cell type:

other: TA 98, 100, 1535, 1537, 1537, 1538; E. coli WP2 uvrA (trp+ reversion)

Metabolic activation:

with and without

Metabolic activation system:

rat liver S-9 mix

Test concentrations with justification for top dose:

3 - 3333 ug/plate (series of 7 sequential doses)

Details on test system and experimental conditions:

Liver S-9's were prepared from male Fischer 344 rats, B6C3F1 [C57B16 X C3H(He)] mice, and Syrian hamsters. The rats and mice were supplied to all laboratories by the NCI Carcinogenesis Testing Program and the hamsters were obtained by each laboratory from different suppliers. Livers were used from animals either without treatment or following treatment with Aroclor 1254 as described by Ames et al [1975]. The S-9 activation mixes were prepared daily, as needed.
The chernicals were from the Same batch used for the in vivo carcinogenicity bioassays conducted by the NCI/NTP. Each chemical was acquired by the NC.I Repository from the laboratory that had performed the in vivo bioassay and was reanalyzed for chemical purity (Midwest Research Institute, Kansas City, MO or Radian Corp., Austin, TX). Chemicals were not selected on the basis of the in vivo carcinogenicity test results because these results were not available, at that time, for all chemicals. Rather, an attempt was made to select those chemicals for which the experimental design (50 animalslgroup) was expected to provide conclusive carcinogenesis results.
The majority of chemicals were tested by the plate-incorporation procedure.
Each laboratory was asked to make its independent assessment of the dose ranges to be tested based on the solubility and toxicity of the test chemicals, but not to exceed 10.0 mg/plate. The doses were to be ordered in half-log increments. Chemicals were tested without activation, and with uninduced and Aroclor 1254-induced S-9's from rats, mice, and hamsters. All plates were prepared in triplicate, and concurrent positive and negative controls were run at all times.

Results and discussion

Test results

Species / strain:

other: TA 98, 100, 1535, 1537, 1537, 1538; E. coli WP2 uvrA (trp+ reversion)

Metabolic activation:

with and without

Genotoxicity:

negative

Cytotoxicity / choice of top concentrations:

not specified

Vehicle controls validity:

not specified

Untreated negative controls validity:

not specified

Positive controls validity:

not specified

Remarks on result:

other: all strains/cell types tested

Remarks:

Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:

Interpretation of results (migrated information):
negative